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Abstract
Background: Measurement of the intima-media thickness (IMT) in the peripheral arteries
leads to better stratification of cardiovascular risk. This is of great importance in patients with
chronic renal insufficiency, who are particularly vulnerable to developing atherosclerotic le-
sions. The aim of the study was to evaluate whether parameters of renal insufficiency and
selected risk factors of atherosclerosis influence IMT in the peripheral arteries.
Methods: The study population comprised 231 patients submitted to coronary angiography
with ultrasonographic assessment of the common carotid artery (CCA), carotid artery bulb
(CB) and common femoral artery (CFA) made contemporaneously with evaluation of IMT
and atherosclerotic plaques. Renal function as well as selected clinical and biochemical risk
factors of atherosclerosis were assessed. Two subgroups were analysed: 200 patients with
coronary heart disease confirmed angiographically (study group) and 31 patients without
coronary lesions (control group).
Results: Significant negative correlation was found between glomerular filtration rate and
IMT values in CCA (p < 0.001) as well as in CB (p < 0.05). Patients with abnormal glucose
metabolism had significantly higher IMT values in CCA (0.95 ± 0.30 vs. 0.87 ± 0.20;
p = 0.034). Hypercholesterolaemia did not influence the IMT values in CCA and CFA. There was
no correlation between body mass index and IMT.
Conclusions: Patients with chronic renal insufficiency presented higher values of IMT in
CCA. The measurement of IMT appears to be a valuable non-invasive method of diagnosing
preclinical stages of atherosclerosis in the described group of patients. (Cardiol J 2007;
14: 59–66)
Key words: intima-media thickness of peripheral arteries, renal function,
cardiovascular risk factors
Introduction
Persons with chronic renal insufficiency, partic-
ularly those requiring renal replacement therapy,
constitute the group of patients most vulnerable
to developing atherosclerotic lesions in the
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cardiovascular system, irrespective of their status with
regard to the traditional risk factors [1–3]. Specific
cardiovascular risk factors related directly to chronic
renal disease include decreased glomerular fil-
tration rate (GFR), proteinuria, increased activity
of the renin-angiotensin-aldosterone system, hyper-
volaemia caused by overhydration, disturbances of
the calcium-phosphate metabolism, dyslipidaemia
and anaemia [4]. Pathophysiology of ischaemic heart
disease in patients with nephropathies is different
from that in the general population in that athero-
sclerotic plaques are more calcified, and the proc-
ess affects not only the large epicardial arteries but
also the smaller arterioles. Coronary reserve is
decreased, and so is the availability of nitric oxide
and the activity of NO synthesis inhibitors. Hyper-
trophy/hyperplasia of the coronary arterioles
decreases their capacity for relaxation, and the de-
creased number of capillaries within the myocar-
dium disrupts oxygen diffusion [5–7]. All the above-
mentioned data maintain interest in the cardiovas-
cular factors affecting patients with chronic renal
insufficiency.
Various methods of assessment of the arterial
system are currently available. Coronary angiogra-
phy is the gold standard in diagnosing lesions of the
coronary arteries. However, it is an invasive meth-
od and therefore detailed criteria of patient qualifi-
cation have been drawn up [8]. Non-invasive tech-
niques, including ultrasonographic measurement of
the intima-media thickness (IMT) or of the flow-
mediated dilatation (FMD), are of increasing clini-
cal significance. New diagnostic modalities also in-
clude the detection of calcium deposits within the
coronary arteries (so-called calcium scoring) or
their direct visualisation with the aid of electron-
beam computed tomography (EBCT) or magnetic
resonance (MRI). Multi-row (even 64-row) tomog-
raphy enables the coronary blood vessels to be vis-
ualised extremely precisely [9]. Non-invasive diag-
nostic methods are of particular importance in an
asymptomatic population, since they contribute
additional data to the established risk factors and
permit better risk stratification of adverse cardio-
vascular episodes [10].
Increased thickness of the intima-media com-
plex, detected in ultrasonography, occurs even in
the early developmental stages of atherosclerosis
and correlates with other traditional risk factors as
well as with the clinical presentation [11–13]. More-
over, Held et al. [14] demonstrated that atheroscle-
rotic plaques and the assessment of IMT in the ca-
rotid artery allow a patient’s risk of ischaemic heart
disease to be assessed.
The aim of the study was to evaluate whether
parameters of renal insufficiency and selected risk
factors of atherosclerosis influence IMT in the pe-
ripheral arteries.
Methods
The study population was recruited among pa-
tients of the Department of Cardiology of the Med-
ical University of Białystok hospitalised between
2001 and 2003. The study included male patients
aged from 18 to 65 years, who were qualified for
coronary angiography and who at the same time
underwent transthoracic echocardiography and ul-
trasonographic evaluation of peripheral arteries.
Selected clinical parameters and biochemical risk
factors of atherosclerosis as well as renal function
were assessed. Criteria of exclusion were previous-
ly diagnosed diabetes mellitus, symptomatic oblit-
erative atherosclerosis of the lower limb arteries
and severe arterial hypertension.
The study population included 231 patients. On
the basis of images of the coronary arteries two
groups of patients were identified: the study group,
comprising 200 patients with coronary heart disease
confirmed in angiography, and the control group of
31 patients with no significant coronary lesions
detected. Coronary artery narrowing of over 50%
of the vessel lumen was considered significant.
Detailed patient characteristics are presented in
Table 1.
Clinical evaluation of each patient included meas-
urement of arterial pressure, resting ECG and exer-
cise test, transthoracic echocardiography, coronary
angiography and ultrasonography of the carotid and
femoral arteries. Laboratory tests included total cho-
lesterol, LDL and HDL cholesterol fractions, serum
triglycerides, plasma fibrinogen, platelet count and
oral glucose tolerance test. Indications for coronary
angiography were assessed on the basis of a patient’s
clinical presentation and the results of accessory in-
vestigations according to the standards of the Polish
Cardiac Society. Coronary angiography was performed
in a routine manner via the femoral artery.
Carotid and femoral artery ultrasonography
was performed using the Sonos 5500 device with
a linear probe of 3–11 MHz frequency. Additionally,
the software enabling evaluation of the peripheral
arteries in B-mode presentation was used, as de-
scribed previously [15]. The parameters evaluated
included the thickness of IMT and the presence of
atherosclerotic plaques within the vessel.
The common carotid artery (CCA) was evaluat-
ed 10 mm from its bulb and the common femoral
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artery (CFA) 10 mm before the origin of the deep fem-
oral artery. In each of the vessel segments assessed
two measurements of IMT were performed and their
results were averaged. Maximal measured IMT val-
ues were considered. Atherosclerotic plaques were
defined as focal IMT values of over 1.3 mm.
Renal function was assessed through measurement
of creatinine level and GFR, calculated according to
the Cockcroft-Gault method: GFR = (140 – age) ×
× body mass [kg]/72 × serum creatinine level. The
following classification of chronic renal insufficien-
cy stages was adopted (according to the Kidney Dis-
ease Outcomes Quality Initiative, K/DOQI):
— stage 1: GFR > 90 ml/min;
— stage 2: GFR of 60–90 ml/min — occult renal
insufficiency;
— stage 3: GFR of 30–60 ml/min — overt com-
pensated renal insufficiency;
— stage 4: GFR of 15–30 ml/min — advanced re-
nal insufficiency;
— stage 5: GFR < 15 ml/min — end-stage renal
insufficiency.
Creatinine levels below 1.5 mg/dl in men were
described as normal.
Statistical analysis
The measurement results were submitted to
statistical analysis. Arithmetical mean values and
standard deviation were calculated for measurable
characteristics, and quantity percentage distributions
were determined for qualitative characteristics.
Pearson’s correlation coefficients were calculated for
continuous characteristics of normal distribution and
Spearman’s coefficients for characteristics of
non-normal distribution.
The normal distribution was verified using
Kolmogarov’s test. For intergroup comparisons of
characteristics of normal distribution, Student’s
t-test was used, and in cases of non-normal distri-
bution the Mann-Whitney test was used. Intergroup
comparisons of qualitative data were performed
using the c2 test. The level of statistical significance
was designated as p < 0.05. Calculations were per-
formed using the SPSS 8.0 PL and Statistica 6.0 PL
software.
All the patients gave their consent for partici-
pation in the study. The approval of the local Ethi-
cal Committee was obtained.
Results
As presented in Table 1, patients in the study
group were older, heavier smokers, had higher diasto-
lic blood pressure, lower levels of HDL cholesterol
and higher levels of triglycerides and fibrinogen and
higher platelet counts. They more often experienced
disturbances of glucose metabolism. Ejection fraction
in echocardiography was significantly lower in the
study group compared to the control group. There
were no significant differences in creatinine levels
between the two groups but patients in the study
group had significantly lower GFRs.
Table 1. Patient characteristics.
Study group (n = 200) Control group (n = 31) p
Age (years) 52.8 ± 8.4 45.9 ± 10.5 < 0.001
Smoking 137 (68.5%) 11 (35.5%) < 0.001
Body mass index [kg/m2] 27.6±3.8 26.8±3.3 NS
Systolic blood pressure [mm Hg] 142.7±20.6 136.1±19.9 NS
Diastolic blood pressure [mm Hg] 92.1±13.4 85.6±11.5 < 0.05
Total cholesterol [mg%] 181.7±37.1 174.0±32.9 NS
LDL cholesterol [mg%] 112.2±33.5 104.0±28.9 NS
HDL cholesterol [mg%] 38.3±8.6 44.5±13.5 0.05
Triglycerides [mg%] 156.0±65.0 120.3±36.2 < 0.01
Diabetes* 39 (19.5%) 1 (3.2%) < 0.01
Abnormal fasting glycaemia* 8 (4%) 0 (0%) 0.0001
Impaired glucose tolerance* 65 (32.5%) 5 (16.1%) 0.0001
Creatinine [mg%] 1.065±0.20 1.012±0.18 NS
Glomerular filtration rate [ml/min] 97.3±25.1 109.9±30.0 0.01
Fibrinogen [mg%] 423.2±110.8 364.8±124.4 < 0.01
Platelets [× 1000/mm3] 231.8±80.3 198.1±54.1 < 0.05
Ejection fraction (%) 46.2±8.3 52.0±13.3 < 0.01
*Disturbances of glucose metabolism diagnosed during hospitalisation.
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Renal function and IMT
In both groups there were few patients with
creatinine levels > 1.5 mg/dl (4% patients in study
group and 3.2% patients in the control group). In
the study group a GFR of over 90 ml/min was ob-
served in 56% patients (112 persons), a GFR of
60–90 ml/min in 39% patients (78 persons), and val-
ues of 30–60 ml/min in 4.5% patients (9 persons).
In the control group as many as 74.2% men had GFR
values over 90 ml/min, and only 25% patients had
filtration rates between 60–90 ml/min; there were
no patients with a GFR below 60 ml/min (Fig. 1).
There was significant negative correlation between
GFR and IMT values measured in CCA (p < 0.001)
(Fig. 2) and in the bulb of CCA (p < 0.05). In the
control group no such correlation was observed. Nor
was there any significant relationship between GFR
values and the incidence of atherosclerotic plaques
in the peripheral arteries. Moreover, filtration rates
were lower in patients with three-vessel disease
compared to the rates observed in patients with one
or two-vessel stenosis (p < 0.05). Of the tradition-
al cardiovascular risk factors analysed, it was only
the occurrence of diabetes and the level of glyco-
sylated haemoglobin that correlated with decreased
GFR (p < 0.05).
Disturbances in glucose metabolism and IMT
In the study group, the oral glucose tolerance
test (OGTT) revealed abnormalities of glucose
metabolism in 112 patients (56%), of whom
8 (4%) had abnormal fasting glycaemia, 65 (32.5%)
had impaired glucose tolerance and 39 subjects
(19.5%) had type 2 diabetes (diagnostic criteria ac-
cording to WHO) (tab. 2). In the control group dis-
turbed glucose metabolism was diagnosed in 6 pa-
tients, including 5 persons with impaired glucose
tolerance and a man diagnosed with diabetes. Twen-
ty five patients (80.6%) in the control group showed
no alteration in glucose metabolism. Individuals with
abnormal OGTT results had significantly higher val-
ues of IMT in CCA (0.95 ± 0.30 vs. 0.87 ±
± 0.20; p = 0.034). No significant differences in IMT
values were observed in CCA bulb (1.31 ± 0.53 vs.
1.31 ± 0.57; p = NS) and in CFA (1.31 ± 0.62 vs. 1.36 ±
± 0.68; p = NS) between the patients with abnormal
glucose metabolism and the healthy subjects (Fig. 3).
Age, body mass, arterial pressure and IMT
The study group consisted of 125 individuals
(62.5%) aged over 50 years and 75 (37.5%) aged
below 50 years. Statistically significant differences
were observed between the two age subgroups with
respect to IMT in CCA (0.95 ± 0.3 vs. 0.85 ± 0.2;
p = 0.002) and IMT in CCA bulb (1.41 ± 0.6 vs.
1.15 ± 0.3; p = 0.001). Patients above and below
50 years of age did not differ significantly with re-
spect to IMT values in the femoral arteries.
Normal body mass index values (BMI < 25)
were observed in 51 patients in the study group,
102 patients were overweight (BMI of 25–30), and
obesity was diagnosed in 47 subjects (BMI > 30).
There was no correlation between BMI and IMT
values, despite the fact that 51% patients in the
study group were overweight and 23.5% obese.
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Figure 1. Glomerular filtration rates (GFR) in patients
from the study and the control group.
Figure 2. Results of intima-media thickness (IMT) measu-
rement in the common carotid artery (CAA) and glomeru-
lar filtration rates (GFR) in patients from the study group.
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Elevated systolic arterial pressure of ≥140 mm Hg
was noted in 121 patients (60.5%) in the study group
and 127 subjects (63.5%) had diastolic pressure val-
ues greater than 90 mm Hg. The IMT measurement
values correlated with diastolic pressure (p = 0.048).
Disturbances in lipid metabolism and IMT
Total cholesterol levels of > 200 mg% were
found in 57 patients (29%), and LDL cholesterol
levels of > 100 mg% with HDL cholesterol < 40 mg%
were observed in 122 patients (61%). Triglyceride
levels of over 150 mg% were noted in 90 individu-
als (45%). Elevated total and LDL cholesterol had
no influence upon the thickness of the intima-me-
dia complex in CCA and CFA.
Discussion
Previously published data, including the au-
thors’ own observations, suggest the occurrence of
significantly greater IMT values in the peripheral
arteries in patients with important coronary artery
stenoses as compared to individuals with no abnor-
malities in coronary angiography [16, 17]. These
findings confirm the role of IMT measurement in
the peripheral arteries in predicting the develop-
ment of atherosclerotic lesions in the coronary
arteries. The aim of the present study was to ana-
lyse the potential relationship between IMT values
in CCAs and selected cardiovascular risk factors,
with particular emphasis on parameters of renal
function.
Patients with chronic renal insufficiency run
a significantly greater risk of developing cardiovas-
cular complications. Greater IMT values in the
carotid arteries were observed in patients before
dialysis [18], in those requiring dialysis and in recip-
ients of renal grafts [19, 20] as compared to subjects
Table 2. Intima-media thickness (IMT) in the peripheral arteries and disturbances in glucose
metabolism.
Patients with Patients with abnormal p
normal OGTT (n = 88)  OGTT (n = 112)
Age (years) 51.6±8.6 53.8±8.1 NS
IMT of CCA [mm] 0.87±0.20 0.95±0.30 0.034
IMT of CCA bulb [mm] 1.31±0.57 1.31±0.53 NS
IMT of CFA [mm] 1.31±0.62 1.36±0.68 NS
Plaques in CCA 3 (3.4%) 10 (9%) NS
Plaques in CCA bulb 30 (34%) 48 (43%) NS
Plaques in CFA 48 (54.5%) 52 (46%) NS
Body mass index [kg/m2] 26.8±3.6 28.2±3.8 0.02
Triglycerides [mg%] 143.7±59.9 165.6±67.4 0.01
Total cholesterol [mg%] 179.2±40.5 183.7±34.3 NS
HDL cholesterol [mg%] 39.0± 8.7 37.8±8.5 NS
LDL cholesterol [mg%] 111.4±37.2 112.7±30.5 NS
Insulin level in OGTT 0 min [mUI/ml] 7.75±2.7 10.8±5.7 0.02
Insulin level in OGTT 120 min [mUI/ml] 40.0±35.5 112.4±101.3 0.0001
OGTT — oral glucose tolerance test; IMT — intima-media thickness; CCA — common carotid artery; CFA — common femoral artery
Figure 3. Results of intima-media thickness (IMT) me-
asurement in common carotid artery (CCA), carotid bulb
(CB) and common femoral artery (CFA) and disturban-
ces in glucose metabolism.
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with normal renal function. Only the group studied
by Konings [21] failed to show this correlation.
In the population presented here a high per-
centage of patients with abnormal renal function
were observed among male subjects with coronary
heart disease verified through angiography. Stage 2
of chronic renal insufficiency (a GFR of 60–89 ml/min)
was identified in almost 40% of patients and stage 3
(GFR of 30–59 ml/min) in 4.5% patients. Addition-
ally, a significant correlation was found between
decreased GFR and increased thickness of the in-
tima-media complex in CCA and its bulb. Howev-
er, our study, in contrast to those of other authors
[22], demonstrated no relationship between creat-
inine levels and IMT values in the peripheral arter-
ies. This is compatible with the current recommen-
dations of the Kidney Disease Outcomes Quality
Initiative (K/DOQI), which suggests calculating
GFR instead of using creatinine level measure-
ments for assessment of renal function.
Multivariate analysis showed that patient age
and GFR are independent factors influencing IMT
values in CCA. This observation is in agreement
with the results published by Ishimura et al. [23].
On the other hand, Litwin et al. [24] observed sig-
nificantly greater IMT values in children with
chronic renal insufficiency, which emphasises the
role of IMT measurement as an early marker of
atherosclerosis development in patients with im-
paired renal function.
The present study shows no correlation between
GFR and the occurence of atherosclerotic plaques in
the peripheral arteries, which probably resulted from
the fact that a major part of the study group consisted
of patients with mild or moderate renal insufficiency.
Reports in the literature that demonstrate a high in-
cidence of atherosclerotic plaques are based on pa-
tients with end-stage renal disease [25].
As with the findings of Rubenfire et al. [26],
a close correlation between IMT and patient age,
abnormalities of glucose metabolism and diastolic
blood pressure was confirmed in the present study.
The influence of patient age upon the thickness of
the intima-media complex in CCA was also report-
ed by Gariepy et al. [27]. Although almost half the
patients in the study group were overweight and
23.5% were obese, there was no relationship
between BMI and IMT values, as reported by the
above-mentioned authors. Zanchetti et al. [28] em-
phasised the influence of systolic (but not diastolic)
blood pressure upon IMT values in the carotid
arteries. In the study presented here, no such in-
fluence was attributable to systolic pressure, which
could be explained by the fact that antihypertensive
agents had previously been administered to over
half the patients. Similarly, elevated total and LDL
cholesterol in the study group did not correlate with
IMT values in CCA. Such findings have been report-
ed by other authors [29] but the patients observed had
significant hypercholesterolaemia, whereas in the
present population approximately 60% of patients had
mild lipid abnormalities (moderately elevated LDL
and decreased HDL cholesterol).
Smoking significantly influenced IMT values in
CFA and the incidence of atherosclerotic plaques
in this vessel but not the IMT in CCA, findings
which were similarly to those of Salonen and Salo-
nen [30]. In the present population, fibrinogen lev-
els correlated with IMT in CCA but not in CFA, as
reported by the above-mentioned authors.
The results of the Insulin Resistance Athero-
sclerosis Study (IRAS) demonstrated that IMT in
CCA was 70 mm greater in diabetic patients than in
normoglycaemic subjects [31]. The Atherosclero-
sis Risk in Communities Study (ARIC) confirmed
a positive but not significant correlation between
IMT in the carotid artery and postprandial glycae-
mia [32], as was also observed by Sun et al. [33].
A confirmed diagnosis of diabetes correlated with
the occurrence of atherosclerotic plaques in the ca-
rotid artery but impaired glucose tolerance had no
influence on increased risk of atherosclerosis [34].
In the population presented here patients with ab-
normal glucose metabolism demonstrated through
OGTT (abnormal fasting glycaemia, impaired glu-
cose tolerance and diabetes) showed significantly
greater thickness of the intima-media complex in
CCA only but not in the carotid bulb or CFA. Lack
of significantly increased IMT in the peripheral ar-
teries outside CCAs could be explained by the fact
that the patients observed had no previous distur-
bances of glucose metabolism and therefore athero-
sclerotic lesions in their peripheral arteries were
not advanced. According to data published in the
literature, diabetes increases the risk of adverse
cardiovascular events from twofold to fourfold [35].
Moreover, the progression of IMT in the carotid
arteries was observed to be twice as rapid in dia-
betic patients, and this was not slowed down by
hypoglycaemic treatment [31]. Early identification
of diabetic subjects and assessment of cardiovas-
cular risk factors, including the value of IMT in
CCA, could therefore lead to the application of pri-
mary prophylaxis, thus preventing the occurrence
of vascular complications.
To sum up, it should be noted that increased
IMT in CCA in patients with traditional risk factors
allows them to be designated to the high-risk group
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and warrants administration of adequate therapy
aimed at modifying these risk factors. Aggressive
therapy for risk factors in patients with peripheral
arterial disease was previously demonstrated to
delay the progressive accumulation of intima-me-
dia plaques [36] or even to reduce IMT [37], which
on clinical grounds reduced the incidence of adverse
cardiovascular episodes.
Conclusions
1. The present study confirms the close relation-
ship between IMT values in the CCAs and se-
lected cardiovascular risk factors, including
patient age, abnormalities of glucose metabo-
lism, diastolic blood pressure and fibrinogen
level.
2. There was a significant negative correlation be-
tween GFRs and IMT values in CCA and its
bulb.
3. Measurement of IMT in CCA and its bulb might
be a valuable non-invasive tool in assessment
of the preclinical stage of atherosclerosis in
patients with impaired renal function. This
would permit identification of patients at par-
ticularly high risk of cardiovascular events
and early introduction of prophylactic meas-
ures.
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